| V |
| v. Dijk N. |
- |
DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT |
| v. Kügelgen I. |
- |
HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS |
| v. Mackensen S. |
- |
DEVELOPMENT OF A SPECIALISATION PROGRAM FOR HAEMOPHILIA NURSES IN ITALY (SPHINX) |
| |
- |
PREFERENCES TOWARDS COAGULATION FACTOR CONCENTRATES USED TO TREAT HEMOPHILIC PATIENTS WITH INHIBITORS: THE PATIENTS', PHYSICIANS' AND PHARMACISTS' PERSPECTIVE |
| Vaccarino A. |
- |
ANTIPHOSPHOLIPID ANTIBODY TESTING IN PIEMONTE AND VALLE D'AOSTA: A MULTILABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAM |
| Vaday G.G. |
- |
FIBRINOGEN SYNTHESIZED BY CANCER CELLS AUGMENTS THE PROLIFERATIVE EFFECT OF FGF-2 |
| Vadim T. |
- |
THE INFLUENCE OF DIFFERENT ANTISEPTICS UPON THE IN VITRO PLATELET ACTIVITY IN PATIENTS WITH PERIODONTITIS TREATED BY AUTOLOGOUS PRP TRANSPLANTATION |
| Vainchenker W. |
- |
FROM HEMATOPOIETIC STEM CELLS TO PLATELETS |
| Vakhtangadze T.K. |
- |
CORRELATION OF HDL CHOLESTEROL WITH SOME LABORATORY PARAMETERS AND CAROTID ARTERIES ATHEROSCLEROTIC LESIONS IN PATIENTS WITH HEART ISCHEMIC DESEASES |
| Valdes C. |
- |
ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION |
| Valdré L. |
- |
THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A |
| Valdre L. |
- |
NO INCREASED SIGNS OF ATHEROSCLEROTIC ALTERATIONS IN CARRIERS OF INHERITED THROMBOPHILIA WITH OR WITHOUT PREVIOUS VENOUS THROMBOSIS |
| Valdrè L. |
- |
EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES |
| |
- |
THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY |
| Valente S. |
- |
HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION |
| |
- |
ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS |
| Valente V.R.H. |
- |
PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS |
| Valente S. |
- |
GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS |
| Valentino L.A. |
- |
PRIMARY HUMAN SYNOVIAL CELLS PROLIFERATE IN RESPONSE TO HEMOGLOBIN AND WHOLE BLOOD |
| |
- |
THE IMPACT OF JOINT BLEEDING AND SYNOVITIS ON PHYSICAL ABILITY AND JOINT FUNCTION |
| |
- |
LOCAL INTRAARTICULAR EXPRESSION OF FACTOR IX FROM ADENO-ASSOCIATED VIRUS (AAV) VECTORS PREVENTS DEVELOPMENT OF HEMOPHILIC ARTHROPATHY |
| Valentino M. |
- |
SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION |
| Valentino L.A. |
- |
VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS |
| Valentino L. |
- |
REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B |
| Valentino L.A. |
- |
SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE |
| |
- |
FACTOR IX CONCENTRATED IN THE JOINT SPACE PROTECTS HEMOPHILIA B MICE FROM BLEEDING-INDUCED JOINT DETERIORATION IN THE ABSENCE OF CIRCULATING FACTOR IX |
| Valetti C. |
- |
MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES |
| Valgañón M. |
- |
CYTOKINE-INDUCED MONOCYTE-ENDOTHELIAL CELL INTERACTIONS: EFFECT ON PAI-1 LEVELS |
| Valgimigli M. |
- |
FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION |
| |
- |
TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION |
| Válková V. |
- |
MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE |
| Valles J. |
- |
EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL |
| |
- |
DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING |
| |
- |
EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K |
| |
- |
INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY |
| Vallez M. |
- |
ANTITHROMBOTIC ACTIVITY OF THE TP-RECEPTOR ANTAGONIST TERUTROBAN ON FOLTS-LIKE AND FECL3 INDUCED RAT MODELS OF THROMBOSIS |
| Vallve C. |
- |
WHAT IS THE CLINICAL IMPACT OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY? |
| Valsecchi C. |
- |
DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS |
| Van Aken H.K. |
- |
ACTIVATED PLATELETS ENHANCE THE ADHERENCE TO AND INVASION OF ENDOTHELIAL CELLS BY STAPHYLOCOCCUS AUREUS |
| Van Aken H. |
- |
THROMBOSPONDIN-1 INHIBITS PLATELET AND MONOCYTE ACTIVATION BY HOCL-OXIDISED PROTEINS |
| van Beers E.J. |
- |
ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION |
| |
- |
MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE |
| Van Belle E. |
- |
METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES |
| van Belle E. |
- |
DRUG ELUTING STENTS: RESTENOSIS VERSUS THROMBOSIS ? |
| Van Berkel T.J.C. |
- |
ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS |
| van Berkel T.J.C. |
- |
EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS |
| van Bokhoven M. |
- |
ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME |
| van Cott K.E. |
- |
N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX |
| Van Cott E.M. |
- |
EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY |
| Van Cott E. |
- |
PEDIATRIC DOSING OF AND EXPERIENCE WITH FONDAPARINUX IN DEEP VENOUS THROMBOSIS |
| van de Reijt F.H.J. |
- |
EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS |
| Van de Walle G.R. |
- |
NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2 |
| Van de Water N. |
- |
CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI |
| van den Berg M.H. |
- |
FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A |
| van den Berg H. |
- |
WASHOUT PERIOD AND FVIII:C IN PATIENTS WITH SEVERE HEMOPHILIA A |
| van den Berg H.M. |
- |
DISCORDANT ANTIBODY RESPONSE IN MONOZYGOTIC TWINS WITH SEVERE HAEMOPHILIA A |
| van den Berg M. |
- |
LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII |
| van den Berg H.M. |
- |
PHENOTYPE HETEROGENEITY IN SEVERE HAEMOPHILIA |
| van den Besselaar A.M.H.P. |
- |
A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS |
| van den Besselaar T. |
- |
EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES |
| van den Besselaar A.M.H.P. |
- |
COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY |
| |
- |
LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY |
| |
- |
QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA |
| |
- |
COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE |
| van den Besselaar T.A.M. |
- |
PERFORMANCE EVALUATION OF THE COAGUCHEK XS SYSTEM IN ROUTINE PATIENT ANTICOAGULATION MANAGEMENT CLINICS IN ISRAEL |
| van den Dool E. |
- |
COMPARATIVE STUDY ON APTT REAGENTS |
| van den Goor J.M. |
- |
RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS |
| van der Bom J.G. |
- |
SELF-RATED HEALTH PREDICTS MORTALITY IN PATIENTS WITH HEMOPHILIA |
| |
- |
WASHOUT PERIOD AND FVIII:C IN PATIENTS WITH SEVERE HEMOPHILIA A |
| |
- |
POLYMORPHISMS IN COAGULATION FACTORS ARE NOT ASSOCIATED WITH THE RISK OF RECURRENT MAJOR ARTERIAL CARDIOVASCULAR EVENTS IN MEN AFTER A FIRST MYOCARDIAL INFARCTION: RESULTS OF 11 YEARS FOLLOW-UP |
| |
- |
LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS |
| |
- |
CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS |
| van der Kallen C.J.H. |
- |
MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E |
| van der Krabben M.D. |
- |
POLYMORPHISMS IN COAGULATION FACTORS ARE NOT ASSOCIATED WITH THE RISK OF RECURRENT MAJOR ARTERIAL CARDIOVASCULAR EVENTS IN MEN AFTER A FIRST MYOCARDIAL INFARCTION: RESULTS OF 11 YEARS FOLLOW-UP |
| van der Linden I.K. |
- |
CIRCULATING MICROPARTICLE (MP)-ASSOCIATED TISSUE FACTOR (TF) ACTIVITY AND THROMBOSIS IN CANCER PATIENTS |
| van der Linden C.T.M. |
- |
PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS |
| van der Meer J. |
- |
THROMBIN ACTIVATBLE FIBRINOLYSIS INHIBITOR (TAFI) IS NOT ASSOCIATED WITH FETAL LOSS; A RETROSPECTIVE STUDY |
| |
- |
INCREASED TAFI LEVELS AND THE RISK OF THROMBOEMBOLISM |
| |
- |
PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS |
| |
- |
VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION |
| |
- |
HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME |
| van der Meer F.J.M. |
- |
COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY |
| van der Meer J. |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY |
| van der Meer F.J.M. |
- |
A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS |
| van der Meer F. |
- |
EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES |
| van der Meer J. |
- |
HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY |
| van der Meer F.J.M. |
- |
COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE |
| |
- |
QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA |
| van der Meer J. |
- |
THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM? |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY |
| van der Meer F.J.M. |
- |
DAILY VITAMIN K SUPPLEMENTATION IMPROVES STABILITY OF TREATMENT WITH VITAMIN K ANTAGONISTS |
| van der Meer J. |
- |
CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY |
| van der Meijden P.E.J. |
- |
CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION |
| |
- |
INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES |
| |
- |
SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY |
| |
- |
DETECTION OF ANTI-HAEMOSTATIC EFFECT OF PLASMA DILUTION VIA THROMBIN GENERATION |
| |
- |
DUAL EFFECT OF PLATELET-DERIVED MATRIX METALLOPROTEINASES ON OCCLUSIVE THROMBUS GROWTH |
| Van der Planken M.G. |
- |
THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER |
| Van der Planken M. |
- |
INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9 |
| van der Poll T. |
- |
ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE |
| |
- |
FACTOR XIII IS AN IMPORTANT MEDIATOR IN THE COAGULATING PLASMA INDUCED IL-8 PRODUCTION BY HUMAN LUNG EPITHELIAL CELLS |
| van der Post J.A.M. |
- |
CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY |
| van der Putten H.H.A.G. |
- |
THE EFFECT OF THE INTRONIC PROTHROMBIN 19911G ALLELE ON 3' END MRNA PROCESSING IN RELATION TO THE 20210GA POLYMORPHISM |
| van der Schoot E.C. |
- |
IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS |
| Van der Schoot C.E. |
- |
JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM |
| van der Spoel H.I. |
- |
COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION |
| van der Steege G. |
- |
PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS |
| |
- |
VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION |
| van der Vleuten C. |
- |
COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME |
| van der Voort D. |
- |
ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS |
| |
- |
ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS |
| |
- |
LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS |
| van der Vorst L.P. |
- |
ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL |
| van der Wal A.C. |
- |
ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL |
| van der Wal D.E. |
- |
ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION |
| Van der Westhuizen F.H. |
- |
THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS |
| van der Zwaan C. |
- |
THE FACTOR VIII C1 DOMAIN CONTRIBUTES TO EFFICIENT LRP/LDL RECEPTOR BINDING |
| van Dieijen-Visser M.P. |
- |
MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E |
| van Dijk K. |
- |
WASHOUT PERIOD AND FVIII:C IN PATIENTS WITH SEVERE HEMOPHILIA A |
| van Dongen C.J.J. |
- |
QUALITY OF ORAL ANTICOAGULANT TREATMENT AND RISK OF SUBSEQUENT RECURRENT THROMBOEMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS. A PROSPECTIVE COHORT STUDY |
| van Doormaal F. |
- |
CANCER AND THROMBOSIS: FROM MOLECULAR MECHANISMS TO CLINICAL PRESENTATIONS |
| van Doormaal F.F. |
- |
SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM. THE TROUSSEAU INVESTIGATORS |
| Van Dorsselear A. |
- |
IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES |
| Van Dreden P. |
- |
HIGH CONCENTRATION OF PROCOAGULANT PHOSPHOLIPIDS AND THROMBOMODULIN ACTIVITY ARE FOUND IN PREGNANCY COMPLICATIONS |
| |
- |
THE EFFECT OF HIRUDIN ON THROMBIN GENERATION, APTT AND ECARIN CLOTTING TIME (ECT) |
| |
- |
HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS |
| |
- |
DETECTION OF HYPERCOAGULABILITY IN PATIENTS WITH THYROID CANCER |
| |
- |
A FUNCTIONAL AUTOMATED ASSAY FOR THROMBOMODULIN ACTIVITY IN PLASMA |
| van Eck M. |
- |
EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS |
| Van Eck M. |
- |
ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS |
| van Esser J. |
- |
ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION |
| Van Etten R.A. |
- |
PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS |
| Van Geet C. |
- |
SEVERE GASTRO-INTESTINAL BLEEDING AND THROMBOCYTOPENIA DUE TO AN ANTI-GATA AUTOANTIBODY |
| |
- |
DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS |
| |
- |
HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY |
| van Geffen M.H.A. |
- |
PLASMA PROTEOMICS IN HEMOPHILIA A PATIENTS AFTER FVIII ADMINISTRATION |
| van Giezen J.J.J. |
- |
REDUCED BLEEDING TIME PROLONGATION FOR THE REVERSIBLE P2Y12 ANTAGONIST AZD6140 COMPARED WITH THE THIENOPYRIDINE, CLOPIDOGREL, IN BOTH A RAT AND DOG MODEL OF COMBINED THROMBOSIS AND HEMOSTASIS |
| van Gils A.P.G. |
- |
DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY |
| van Greevenbroek M.M.J. |
- |
MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E |
| van Haren S.D. |
- |
FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A |
| Van Heerde W.L. |
- |
IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME |
| van Heerde W.L. |
- |
THE NIJMEGEN HAEMOSTASIS ASSAY (NHA) IN THE VITRO-STUDY: RELATION WITH HOMOCYSTEINE, B-VITAMIN TREATMENT AND RECURRENCE RISK |
| |
- |
PLASMA PROTEOMICS IN HEMOPHILIA A PATIENTS AFTER FVIII ADMINISTRATION |
| Van Heerde W.L. |
- |
TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE |
| van Heerde W.L. |
- |
THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE |
| |
- |
THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE |
| |
- |
APOLIPOPROTEIN A1 AS A PREDICTOR OF RECURRENT VENOUS THROMBOSIS. RESULTS OF A PLASMA PROTEOMICS APPROACH |
| |
- |
ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS |
| |
- |
THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS |
| van Helden P.M. |
- |
DISCORDANT ANTIBODY RESPONSE IN MONOZYGOTIC TWINS WITH SEVERE HAEMOPHILIA A |
| van Helden P.M.W. |
- |
FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A |
| van Hellemond J.J. |
- |
THE OUTER-SURFACES OF SCHISTOSOMA MANSONI DURING THE LIFE-CYCLE DEMONSTRATE DIFFERENTIAL PROPERTIES TOWARDS PLATELET ADHESION |
| van Hengel J. |
- |
RHOA IS ESSENTIAL FOR MEGAKARYOCYTE SURVIVAL IN VIVO |
| Van Hoef B. |
- |
INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASES IMPAIRS ADIPOSE TISSUE DEVELOPMENT IN MOUSE MODELS OF OBESITY |
| |
- |
DEFICIENCY OF PLASMINOGEN ACTIVATOR INHIBITOR-2 IMPAIRS NUTRITIONALLY INDUCED MURINE ADIPOSE TISSUE DEVELOPMENT |
| |
- |
NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE |
| Van Hoogen P.C.M. |
- |
TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE |
| van Hoogen P.C.M. |
- |
THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS |
| van Hout B. |
- |
RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW |
| van Hylckama Vlieg A. |
- |
A CODING SNP AT THE GPI-ATTACHMENT SITE IN THE TFPI-BETA-SPECIFIC EXON IS ASSOCIATED WITH TFPI LEVELS |
| |
- |
A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS |
| |
- |
SNPS NEAR THE ESTROGEN SULFOTRANSFERASE GENE SULT1E1 AND THE RISK OF VENOUS THROMBOSIS IN RELATION TO ORAL CONTRACEPTIVE USE |
| |
- |
FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS |
| |
- |
VENOUS THROMBOSIS IN THE ELDERLY |
| |
- |
ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE |
| |
- |
AUTO-ANTIBODIES AGAINST EPCR AND THE RISK OF A FIRST DEEP VENOUS THROMBOSIS |
| Van kerckhoven S. |
- |
CATHEPSIN G IS NOT A SPECIFIC AGONIST FOR PROTEASE ACTIVATED RECEPTORS IN PLATELETS |
| Van Kraaij M.G.J. |
- |
TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE |
| van Kraaij M.G.J. |
- |
THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE |
| |
- |
PLASMA PROTEOMICS IN HEMOPHILIA A PATIENTS AFTER FVIII ADMINISTRATION |
| Van Kraaij M.G.J. |
- |
IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME |
| van Kraaij M.G.J. |
- |
THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS |
| van Landeghem B.A.J. |
- |
B-VITAMIN SUPPLEMENTATION LOWERS PLASMA HOMOCYSTEINE CONCENTRATION BUT DOES NOT AFFECT PLASMA METHIONINE AND CYSTEINE CONCENTRATIONS: A POSSIBLE EXPLANATION FOR NEGATIVE RESULTS OF CLINICAL TRIALS |
| van Leeuwen Y. |
- |
BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES |
| |
- |
PREDICTION OF BLEEDING AND THROMBOTIC EVENTS IN PATIENTS WITH MECHANICAL HEART VALVE PROSTHESES TREATED WITH ORAL ANTICOAGULANTS |
| van Minkelen R. |
- |
FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS |
| van Montfoort A.P.A. |
- |
SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY |
| van Mourik J. |
- |
CORRELATION BETWEEN THE POTENCY OF A BETA2-GLYCOPROTEIN I DEPENDENT LUPUS ANTICOAGULANT AND THE LEVEL OF RESISTANCE TO ACTIVATED PROTEIN C |
| van Mourik J.A. |
- |
VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK |
| van Mourik J. |
- |
THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY |
| van Nispen tot Pannerden H. |
- |
PLATELET ARCHITECTURE IN THREE DIMENSIONS |
| van Oerle R. |
- |
ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS |
| |
- |
ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS |
| |
- |
THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION |
| |
- |
THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID |
| |
- |
COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT |
| |
- |
THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS |
| |
- |
THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS |
| |
- |
LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB |
| |
- |
IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS |
| |
- |
THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD) |
| |
- |
LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT) |
| |
- |
COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION |
| |
- |
ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION |
| van Ommen H. |
- |
VENOUS THROMBOSIS AND THE POST THROMBOTIC SYNDROME AFTER FEMORAL CATHETERIZATION |
| van Pampus E.C.M. |
- |
DETECTION OF ANTI-HAEMOSTATIC EFFECT OF PLASMA DILUTION VIA THROMBIN GENERATION |
| van Rooden C.J. |
- |
DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY |
| van Rossum J. |
- |
ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME |
| |
- |
COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME |
| van Schagen M. |
- |
CORRELATION BETWEEN THE POTENCY OF A BETA2-GLYCOPROTEIN I DEPENDENT LUPUS ANTICOAGULANT AND THE LEVEL OF RESISTANCE TO ACTIVATED PROTEIN C |
| van Schooten C.J.M. |
- |
LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII |
| van Sluis G.L. |
- |
CANCER AND THROMBOSIS: FROM MOLECULAR MECHANISMS TO CLINICAL PRESENTATIONS |
| |
- |
FAMILY HISTORY, DEEP VENOUS THROMBOSIS AND THROMBOPHILIA |
| van Son W.J. |
- |
CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION |
| van Stralen K.J. |
- |
TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004 |
| |
- |
INVESTIGATING POSSIBLE MECHANISMS OF THE FACTOR V LEIDEN PARADOX |
| |
- |
MINOR LEG INJURIES INCREASE VENOUS THROMBOTIC RISK FIVE FOLD |
| |
- |
MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004 |
| van 't Veer C. |
- |
ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE |
| |
- |
FACTOR XIII IS AN IMPORTANT MEDIATOR IN THE COAGULATING PLASMA INDUCED IL-8 PRODUCTION BY HUMAN LUNG EPITHELIAL CELLS |
| van Tits B.L.J. |
- |
APOLIPOPROTEIN A1 AS A PREDICTOR OF RECURRENT VENOUS THROMBOSIS. RESULTS OF A PLASMA PROTEOMICS APPROACH |
| van Veen J.J. |
- |
COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A |
| |
- |
THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF) |
| |
- |
IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY |
| |
- |
COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT) |
| |
- |
SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS |
| van Vliet H.A.A.M. |
- |
EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY |
| van Vlijmen B.J.M. |
- |
MEASUREMENT OF THROMBIN GENERATION AND APC-RESISTANCE IN MOUSE PLASMA |
| van Vlijmen E.F.W. |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY |
| Van Vlijmen B. |
- |
NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE |
| van Vlijmen E.F.W. |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY |
| van Werkum J.W. |
- |
IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION |
| |
- |
COMPARISON OF A NEW CARTRIDGE* FOR THE PFA-100 WITH OTHER PLATELET FUNCTION ASSAYS FOR MEASURING THE EFFECT OF CLOPIDOGREL THERAPY IN CARDIOVASCULAR PATIENTS |
| Van Wulfften Palthe A.F.Y. |
- |
JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM |
| van Zandvoort M.A.M.J. |
- |
MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT |
| |
- |
VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO |
| Vancine-Califani S.M.C. |
- |
DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE |
| Vandeberg P. |
- |
A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION |
| VandenDriessche T. |
- |
DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS |
| |
- |
RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER |
| Vandeputte N. |
- |
RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER |
| |
- |
NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2 |
| |
- |
FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L) |
| Vandervoort P. |
- |
THROMBOSPONDIN1 GENE DEFICIENCY ATTENUATES ATHEROSCLEROTIC PLAQUE BURDEN BUT ACCENTUATES INFLAMMATORY CELL PLAQUE CONTENT IN APOE-DEFICIENT MICE |
| |
- |
THROMBOSPONDIN1 GENE DEFICIENCY MODULATES VASCULAR MEDIAL SMOOTH MUSCLE CELL ACTIVATION AND NEOINTIMA FORMATION |
| Vanelli R. |
- |
EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR |
| Vangenechten I. |
- |
THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER |
| |
- |
INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9 |
| Vanhoorelbeke K. |
- |
RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER |
| |
- |
THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA |
| |
- |
THE VWF-GPIB AXIS AS A THERAPEUTIC TARGET |
| |
- |
FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L) |
| |
- |
THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS |
| |
- |
FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE |
| |
- |
DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE |
| |
- |
NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO |
| |
- |
CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS |
| Vanni S. |
- |
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM |
| Vannier J.P. |
- |
CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY |
| Vannucchi A. |
- |
A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT |
| Vannucci M. |
- |
EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY |
| VanSluys J. |
- |
RAP1B IS REQUIRED FOR NORMAL ANGIOGENESIS AND MAPK SIGNALING IN ENDOTHELIAL CELLS |
| Váradi K. |
- |
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS |
| |
- |
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE |
| Varadi K. |
- |
SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE |
| |
- |
THE EFFECT OF APCC AND PCC ON THE GENERATION OF THROMBIN IN HAEMOPHILIA A PATIENTS WITH FVIII INHIBITOR: A CROSS-OVER PHARMACOKINETIC STUDY |
| Varenhorst C. |
- |
GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE |
| |
- |
GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE |
| Varfaj F. |
- |
LEU335 CONTRIBUTES TO THE EFFICIENT PROTEOLYSIS OF FACTOR VIIIA AT ARG336 CATALYZED BY ACTIVATED PROTEIN C |
| Varfolomeyev S.D. |
- |
INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS |
| |
- |
MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS |
| Varga-Szabo D. |
- |
COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO |
| |
- |
UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1 |
| |
- |
AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE |
| Vargová K. |
- |
HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL |
| Vargova K. |
- |
STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE |
| |
- |
CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA |
| |
- |
ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS |
| Varin R. |
- |
CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY |
| |
- |
RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT |
| Varma G. |
- |
AN EVALUATION OF A PHARMACY INPATIENT ANTICOAGULATION SERVICE IN GENERAL & EMERGENCY MEDICINE |
| Varma S. |
- |
INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA |
| Varma N. |
- |
INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA |
| Varol F. |
- |
LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS |
| Varon D. |
- |
TESTING AGONIST-INDUCED PLATELET AGGREGATION BY THE IMPACT-R |
| |
- |
CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER] |
| |
- |
PRO- AND ANTI-ANGIOGENIC CYTOKINES ARE CONDITIONALLY AND SELECTIVELY RELEASED FROM ALPHA-GRANULES UPON PLATELET STIMULATION |
| |
- |
PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS |
| |
- |
THE ROLE OF PLATELET MICROPARTICLES IN ANGIOGENESIS AND TUMOR BIOLOGY |
| |
- |
RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER] |
| Vartholomatos G. |
- |
ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY |
| |
- |
A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS |
| Varvarikis C. |
- |
ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS |
| Varvenne M. |
- |
SUCCESSFUL TREATMENT OF PATIENTS WITH INHIBITORS TO COAGULATION FACTOR VIII AND IX BY TREATING CONCOMITANT HEPATITIS C |
| Vasilenko I. |
- |
THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME |
| Vasiliev S.A. |
- |
AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA |
| Vasiliev D.V. |
- |
AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA |
| Vasilieva T.V. |
- |
PAR1 AGONISTS ACCELERATE ULCER HEALING IN RATS |
| Vasilieva T.M. |
- |
THE MODIFICATION OF PROTEINS BY NON-EQUILIBRIUM PLASMA THE NOVEL TECHNIQUE FOR THE PRODUCTION OF PLATELET AGGREGATION INHIBITORS |
| Vasiljeva I. |
- |
DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA |
| Vasiljevic Z. |
- |
INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM |
| Vasquez J. |
- |
SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN |
| Vásquez L. |
- |
TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION |
| Vasquez J. |
- |
THE SYNERGISTIC EFFECTS OF SYNTHETIC PHOSPHOLIPIDS AND RECOMBINANT TISSUE FACTOR IN THE OPTIMIZATION OF A PROTEIN S ASSAY SENSITIVITY |
| Vasse M. |
- |
HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS |
| |
- |
MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS |
| Vastola M. |
- |
MECHANISMS OF INHIBITION OF THROMBIN-INDUCED PLATELET ACTIVATION BY FIBRINOGEN GAMMA'(408-427) PEPTIDE |
| Vats V. |
- |
EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS |
| Vauterin S. |
- |
THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS |
| |
- |
THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA |
| Vauthier C. |
- |
ASSAY DEVELOPMENT FOR PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEX (FVIIA-AT) |
| Vavilova T. |
- |
THE INFLUENCE OF DIFFERENT ANTISEPTICS UPON THE IN VITRO PLATELET ACTIVITY IN PATIENTS WITH PERIODONTITIS TREATED BY AUTOLOGOUS PRP TRANSPLANTATION |
| |
- |
THE VITAMIN K EPOXIDE REDUCTASE GENE POLYMORPHISMS AND PHARMACOGENETICS OF WARFARIN |
| Vavilova T.V. |
- |
D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS |
| Vavlukis M. |
- |
ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE |
| Vayá A. |
- |
ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION |
| |
- |
PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION |
| Vaya A. |
- |
FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS |
| Vayá A. |
- |
INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE |
| Vaz F.A.C. |
- |
NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER |
| Vazquez R. |
- |
MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE |
| Vdovin V.V. |
- |
HOME TREATMENT WITH RECOMBINANT VIIA FACTOR IN HEMOPHILIA PATIENTS WITH INHIBITOR |
| |
- |
LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA |
| |
- |
HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY |
| |
- |
MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION |
| Vdovin V. |
- |
EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY |
| Veber B. |
- |
RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT |
| Vecchione G.G.V. |
- |
A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS |
| Vecchione G. |
- |
A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS |
| |
- |
A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY |
| Vecsteinas A. |
- |
GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS |
| Vedie B. |
- |
COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC |
| Vedovati C. |
- |
PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION |
| Vedovati M.C. |
- |
PROGNOSTIC VALUE OF TROPONINS IN ACUTE PULMONARY EMBOLISM: A META-ANALYSIS |
| |
- |
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM |
| Veeger N.J.G.M. |
- |
CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME |
| |
- |
THROMBIN ACTIVATBLE FIBRINOLYSIS INHIBITOR (TAFI) IS NOT ASSOCIATED WITH FETAL LOSS; A RETROSPECTIVE STUDY |
| |
- |
INCREASED TAFI LEVELS AND THE RISK OF THROMBOEMBOLISM |
| |
- |
HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY |
| Veenstra D.L. |
- |
THE RELATIVE EFFECTS OF VKORC1 AND CYP2C9 VARIANTS ON CLINICAL OUTCOMES IN WARFARIN PATIENTS |
| Vega-Ostertag M. |
- |
ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION |
| Vega-Ostertag M.E. |
- |
EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS |
| |
- |
ACQUIRED HEMOPHILIA A IN A PATIENT WITH HYDATID DISEASE: A CASE REPORT |
| |
- |
EVALUATION OF LIPOPROTEIN (A) IN ARGENTINIAN WOMEN WITH ADVERSED PREGNANCY OUTCOME |
| Vegh P. |
- |
PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS |
| Velander W.H. |
- |
EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS |
| Veljkovic D. |
- |
RISK FACTORS FOR THROMBOSIS IN CHILDREN |
| Velling T. |
- |
TISSUE FACTOR/FACTOR VIIA COMPLEX REGULATES PDGF-BB-INDUCED CHEMOTAXIS THROUGH SRC FAMILY KINASE SIGNALING |
| Vemeulen S.H.H.M. |
- |
ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH |
| Venco A. |
- |
SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY |
| |
- |
BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM |
| |
- |
METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY |
| Venet C. |
- |
EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS |
| Venica A. |
- |
ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA |
| Venisse L. |
- |
PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY |
| Venti M. |
- |
A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS |
| Ventura J.S. |
- |
AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS |
| Verbeke K. |
- |
SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY |
| Verbeuren T.J. |
- |
NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS |
| |
- |
ANTITHROMBOTIC ACTIVITY OF THE TP-RECEPTOR ANTAGONIST TERUTROBAN ON FOLTS-LIKE AND FECL3 INDUCED RAT MODELS OF THROMBOSIS |
| Verbruggen B. |
- |
PERFORMANCE OF BETHESDA ASSAY AND NIJMEGEN VARIANT IN EXTERNAL QUALITY ASSESSMENT (ECAT) OF FACTOR VIII INHIBITOR ASSAYS |
| |
- |
PLASMA PROTEOMICS IN HEMOPHILIA A PATIENTS AFTER FVIII ADMINISTRATION |
| Verbruggen B.W. |
- |
THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE |
| Verbruggen B. |
- |
THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS |
| Verdiani V. |
- |
DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS? |
| Verdu J.J. |
- |
GENETIC THROMBOPHILIA AND THROMBOSIS OF CEREBRAL VENOUS SINUSES |
| Verdu J.B. |
- |
THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) GENE POLYMORPHISM AND RISK FOR VENOUS THROMBOSIS DISEASE (VTD) |
| Verducci M. |
- |
SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION |
| Verdy E. |
- |
IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION |
| |
- |
THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE |
| |
- |
BRIDGING THERAPY IN PATIENTS TREATED WITH LMWH AND COUMARIN INDUCES DEEP INHIBITION OF THROMBIN GENERATION |
| |
- |
INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA |
| Veréb Z. |
- |
A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD) |
| Verellen C. |
- |
PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A |
| Verga M. |
- |
D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY |
| Vergin C. |
- |
LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE |
| Vergnes C. |
- |
A NOVEL DYSFIBRINOGENEMIA DETECTED BY ELECTROPHORESIS IN A PATIENT PRESENTING WITH FAMILIAL VENOUS THROMBOEMBOLISM |
| Vergona R. |
- |
A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS |
| Vergura P. |
- |
COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS |
| |
- |
A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY |
| Verhamme I.M.A. |
- |
EXOSITES IN THE SUBSTRATE SPECIFICITY OF BLOOD COAGULATION REACTIONS |
| Verheggen B. |
- |
RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW |
| Verhoef S. |
- |
ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION |
| Vericel E. |
- |
THE EFFECTS OF DOCOSAHEXAENOIC ACID IN PLATELETS (AN EX VIVO STUDY) AND IN MEGAKARYOCYTIC CELLS (AN IN VITRO STUDY) |
| Verkleij C.J.N. |
- |
EFFECT OF GLYCATED TAFI AND PLASMINOGEN ON FIBRINOLYSIS |
| Verlato F. |
- |
OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY |
| |
- |
GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT) |
| |
- |
INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY |
| |
- |
BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP |
| |
- |
LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY |
| Vermeer C. |
- |
CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS |
| |
- |
Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease |
| Vermes E. |
- |
A NEW ANTITHROMBOTIC STRATEGY FOR PATIENTS WITH LONG TERM MECHANICAL CIRCULATORY SUPPORT (MCS) |
| Vermeulen S.H.H.M. |
- |
SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE |
| Vermeulen S. |
- |
CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK |
| Vermillard V. |
- |
THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING |
| Vermylen C. |
- |
PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A |
| |
- |
IMPACT OF PROPHYLACTIC ADMINISTRATION OF FFP ON HYPOFIBRINOGENEMIA IN PAEDIATRIC PATIENTS TREATED WITH L-ASPARAGINASE FOR ACUTE LYMPHOBLASTIC LEUKAEMIA |
| Vermylen J. |
- |
RESPONSE VARIABILITY TO ASPIRIN AS ASSESSED BY A PLATELET FUNCTION-ANALYZING DEVICE IN 5,007 SUBJECTS: A SYSTEMATIC REVIEW OF 40 STUDIES |
| Vernhet H. |
- |
SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION |
| Verschraegen I. |
- |
DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS |
| Verschuren F. |
- |
MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL |
| Verso M. |
- |
INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY |
| |
- |
ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY |
| |
- |
EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA |
| |
- |
PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY |
| |
- |
CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY |
| |
- |
DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY |
| Versteeg H.H. |
- |
PDI CHAPERONE FUNCTION ENHANCES TF PROCOAGULANT ACTIVITY |
| Verstuyft C. |
- |
VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY |
| Vertessen F. |
- |
INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9 |
| |
- |
THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER |
| Vertun-Baranowska B. |
- |
PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/4G GENOTYPE MAY INCREASE THE RISK OF THROMBOSIS IN SUBSET OF PATIENTS WITH PROTHROMBIN G20210A GENE MUTATION |
| Veryasov V.N. |
- |
APPLICATION OF AUTOLOGOUS RED BLOOD CELLS CONCENTRATE DERIVED FROM UMBILICAL CORD BLOOD FOR THERAPY OF ANAEMIC NEONATES |
| Verzijlbergen J. |
- |
THE VALUE OF PET- SCANNING IN THE DETECTION OF OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM |
| Vespoli C. |
- |
RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM |
| Vetr H. |
- |
SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE |
| Vettore S. |
- |
THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES |
| |
- |
RETINAL CENTRAL ARTERY OCCLUSION AFTER 10 PILLS OF DROSPIRENONE CONTAINING PREPARATION (YASMIN) |
| |
- |
HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME |
| Veyradier A. |
- |
IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA |
| |
- |
IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA |
| |
- |
EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME) |
| Viallard J. |
- |
TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE |
| Vianelli N. |
- |
PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT |
| Viarengo G. |
- |
VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES |
| Vicaut E. |
- |
HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS |
| Vicente V. |
- |
INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION |
| |
- |
BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS |
| |
- |
IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN |
| |
- |
FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA |
| |
- |
JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA |
| Vicente M. |
- |
LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS |
| Vicente V. |
- |
INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD] |
| |
- |
GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL |
| |
- |
ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS |
| |
- |
ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY |
| |
- |
TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE |
| |
- |
ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION |
| Vicente C.P. |
- |
ACCELERATED ATHEROGENESIS AND NEOINTIMA FORMATION IN HEPARIN COFACTOR II DEFICIENT MICE |
| Vicente M. |
- |
EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT |
| Vicente V. |
- |
PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION |
| |
- |
CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES |
| |
- |
HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN |
| |
- |
BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN |
| Victor M. |
- |
CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B |
| Vidal R. |
- |
DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM |
| Vidaller A. |
- |
THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS |
| Vidovic A.D. |
- |
EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION |
| Vieillefond V. |
- |
SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL |
| Viel K.R. |
- |
GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN |
| Vieux L. |
- |
SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L |
| Viganò M. |
- |
LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM |
| Viglino C. |
- |
FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES |
| Vignoli A. |
- |
THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD) |
| |
- |
DIFFERENTIAL EFFECTS OF RETINOIDS ON THE PROCOAGULANT ACTIVITY (PCA) AND CYTO-DIFFERENTIATION OF LEUKEMIC CELLS FRESHLY ISOLATED FROM ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS |
| |
- |
PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE |
| |
- |
LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS |
| |
- |
ALL-TRANS RETINOIC ACID (ATRA) INHIBITS ENDOTHELIAL ANGIOGENESIS INDUCED BY TUMOR CELLS AND STANDARD FACTORS |
| Vija H. |
- |
PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM |
| Vijapurkar M. |
- |
CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS |
| Vik A. |
- |
THE PREDICTIVE VALUE OF CRP, D-DIMER AND CLINICAL PROBABILITY TO EXCLUDE DVT IN PERSONS ADMITTED TO HOSPITAL FOR DVT |
| Viksna L. |
- |
NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA |
| Vila V. |
- |
DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY |
| |
- |
ATORVASTATIN NEUTRALIZED THE UP-REGULATION OF THROMBOSPONDIN INDUCED BY THROMBIN IN ENDOTHELIAL CELLS |
| Vila J. |
- |
CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER |
| Vila V. |
- |
INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS |
| Vilahur G. |
- |
MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN |
| |
- |
PLAQUE PROGRESSION AND REGRESSION IN ATHEROTHROMBOSIS |
| |
- |
THROMBOXANE A2/PROSTAGLANDIN H2 RECEPTOR BLOCKER (S18886) SHOWS ANTITHROMBOTIC EFFICACY SIMILAR TO ASPIRIN PLUS CLOPIDOGREL IN STENT-INDUCED THROMBOSIS |
| Vilchevska K. |
- |
CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN |
| Villa P. |
- |
PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION |
| |
- |
INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS |
| |
- |
ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION |
| |
- |
EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE |
| |
- |
DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY |
| Villaça P.R. |
- |
MUNCHAUSEN SYNDROME X COAGULOPATHIES |
| |
- |
ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT |
| |
- |
DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS |
| Villalta S. |
- |
PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY |
| Villamil F. |
- |
FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION |
| Villani L. |
- |
APPLICABILITY OF D-DIMER IN RULING OUT VENOUS THROMBOEMBOLISM (VTE) IN ELDERLY MEDICAL PATIENTS: COMPARISON BETWEEN IMMUNOTURBIDIMETRIC AND ELISA (ELFA) METHODS |
| Villar A. |
- |
MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE |
| Villard E. |
- |
THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS |
| Ville Y. |
- |
CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT |
| Villeneuve J. |
- |
HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS |
| Villoutreix B.O. |
- |
DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING |
| Villoutreix B. |
- |
EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS) |
| Villoutreix B.O. |
- |
DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA |
| Viñas H. |
- |
ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION |
| Vinayagam S. |
- |
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ISOLATED ANTI-BETA2 GLYCOPROTEIN I ANTIBODY POSITIVITY |
| Vincelette J. |
- |
A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS |
| Vincent L.M. |
- |
DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913) |
| Vinciguerra C. |
- |
MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING |
| |
- |
SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI) |
| |
- |
DETECTION OF LARGE DELETIONS IN HAEMOPHILIA A: CARRIER DETECTION BY MP/LC (MULTIPLEX PCR/LIQUID CHROMATOGRAPHY) |
| |
- |
CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B |
| Vinh J. |
- |
TYPE III COLLAGEN BINDING PROTEIN (TIIICBP) IS IDENTICAL TO KINDLIN-3, A PROTEIN BELONGING TO A NOVEL FAMILY OF FOCAL ADHESION PROTEINS |
| Vinnikov I. |
- |
FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE |
| |
- |
THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS |
| Vinters H.V. |
- |
A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION |
| Vinuela F. |
- |
A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION |
| Violi F. |
- |
EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN |
| |
- |
OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN |
| |
- |
LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX |
| |
- |
LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION |
| Virdis A. |
- |
BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS |
| |
- |
EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM |
| Viscardi Y. |
- |
EVALUATION OF THE THROMBOELASTOMETRY |
| Vishnevskaya S.M. |
- |
IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS |
| Vispo N.S. |
- |
MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE |
| |
- |
ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION |
| Vissac A.M. |
- |
NEW APPROACH FOR DETECTION OF HEPARIN DEPENDENT ANTIBODIES AND RISK ASSESSMENT FOR HEPARIN INDUCED THROMBOCYTOPENIA |
| |
- |
CLASSIFICATION OF FACTOR V-LEIDEN CARRIERS BY QUANTITATIVELY MEASURING ITS PROCOAGULANT ACTIVITY COMPARATIVELY TO THAT OF FACTOR V |
| |
- |
QUANTITATIVE MEASUREMENT OF FACTOR V-LEIDEN WITH A NEW ONE STEP, CALIBRATED, CLOTTING METHOD |
| |
- |
MICROPARTICLES PROCOAGULANT ACTIVITY IN CITRATED PLASMA |
| |
- |
INCIDENCE OF THE VARIOUS HEPARIN DEPENDENT ANTIBODY ISOTYPES IN A GROUP OF PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA |
| |
- |
FACTORS AFFECTING THE FACTOR VIII:C REACTIVITY WHEN TESTED IN PURIFIED SYSTEMS WITH CHROMOGENIC ASSAYS |
| Visseaux C. |
- |
SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL |
| Viswabandya A. |
- |
NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA |
| |
- |
COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS |
| |
- |
MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA |
| |
- |
POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B |
| |
- |
MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA |
| Vitali M.S. |
- |
COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES |
| Vitkovsky Y.A. |
- |
CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION |
| |
- |
LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS |
| |
- |
THE CARRIAGE OF FV G1691A, FII G20210A, MTHFR C677T GENES IN PATIENTS WITH ISCHEMIC STROKE IN BURYATS AND RUSSIANS |
| |
- |
ROLE OF COLLAGEN IN PLATELET-DEPENDED CD4+ T CELL ADHESION |
| |
- |
LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY |
| |
- |
POSSIBLE MECHANISMS OF THE DEVELOPMENT OF DIC SYNDROME |
| |
- |
CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING |
| Vitsenya M. |
- |
D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS |
| Viuff D. |
- |
EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS |
| |
- |
COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS |
| |
- |
EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS |
| Vivino G. |
- |
RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION |
| Vizcaychipi K. |
- |
HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY |
| Vizintin Cuderman T. |
- |
OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT |
| Vlachova I. |
- |
TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND VON WILLEBRAND FACTOR IN THE ACUTE AND CONVALESCENT PHASE OF ISCHEMIC STROKE |
| Vlahovic G. |
- |
RISK FACTORS FOR THROMBOSIS IN CHILDREN |
| Vlodavsky I. |
- |
HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS |
| |
- |
HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS |
| Vodickova L. |
- |
CONFIRMATION OF EFFICACY, SAFETY AND COST EFFECTIVENESS OF FRAXIPARINE FORTE IN THE OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS |
| Voermans C. |
- |
IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS |
| Vogt A. |
- |
PRESERVATION OF IN VITRO FUNCTION OF PLATELETS STORED IN THE PRESENCE OF A SYNTHETIC DUAL INHIBITOR OF FACTOR XA AND THROMBIN |
| Vohnout B. |
- |
DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK? |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| Voisin P. |
- |
EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA |
| Voisin S. |
- |
SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE |
| Vokó Z. |
- |
FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS |
| Vokurkova D. |
- |
ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY |
| Volf I. |
- |
THROMBOSPONDIN-1 INHIBITS PLATELET AND MONOCYTE ACTIVATION BY HOCL-OXIDISED PROTEINS |
| Völker U. |
- |
PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES |
| Volkov G.L. |
- |
INFLUENCE OF THE STREPTOKINASE 36 KDA FRAGMENT ON THE PLASMIN ACTIVITY |
| Volkov G.G.L. |
- |
THE INFLUENCE OF STREPTOKINASE ON PLATELETS |
| Volpert V. |
- |
WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA |
| Volpin S.M. |
- |
INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE |
| Volteas S.K. |
- |
REPLACING ORAL ANTICOAGULANTS WITH TINZAPARIN SODIUM IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY: SAFETY AND COST CONSIDERATIONS |
| von Auer C. |
- |
BLEEDING COMPLICATIONS IN SURGICAL PATIENTS WITH VON WILLEBRAND'S DISEASE |
| |
- |
RAPID INCREASE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HAEMOPHILIA AND CHRONIC HCV- INFECTION |
| |
- |
DATABASE MANAGEMENT SYSTEM FOR A HAEMOPHILIA COMPREHENSIVE CARE CENTRE |
| von Beckerath N. |
- |
IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION |
| von Bruehl M. |
- |
PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY |
| von Brühl M.L. |
- |
PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO |
| |
- |
THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO |
| von Depka M. |
- |
PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE |
| |
- |
CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME |
| von Eije K. |
- |
FACTOR XIII IS AN IMPORTANT MEDIATOR IN THE COAGULATING PLASMA INDUCED IL-8 PRODUCTION BY HUMAN LUNG EPITHELIAL CELLS |
| von Pape K.W. |
- |
PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY |
| |
- |
IMPACT OF CENTRIFUGATION CONDITIONS ON PLATELETS AND COAGULATION TESTING |
| Voong K. |
- |
URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS |
| |
- |
VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM |
| Voorberg J. |
- |
THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY |
| |
- |
FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A |
| |
- |
HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF |
| |
- |
DISCORDANT ANTIBODY RESPONSE IN MONOZYGOTIC TWINS WITH SEVERE HAEMOPHILIA A |
| Vora S. |
- |
DEEP VENOUS THROMBOSIS IN THE ANTENATAL PERIOD IN A LARGE COHORT OF PREGNANCIES FROM WESTERN INDIA |
| |
- |
THROMBOPHILIA AS A CAUSE OF UNEXPLAINED FETAL LOSS IN INDIAN PATIENTS AN IN DEPTH STUDY |
| |
- |
CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS |
| Vorlova Z. |
- |
BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY |
| |
- |
THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY |
| |
- |
RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD) |
| Vormittag R. |
- |
A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS |
| |
- |
THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154 |
| |
- |
PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA |
| |
- |
SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY |
| |
- |
ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE) |
| |
- |
PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE) |
| Vorobiova E.E.V. |
- |
APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER |
| Vorobiova E. |
- |
CORRELATION OF HDL CHOLESTEROL WITH SOME LABORATORY PARAMETERS AND CAROTID ARTERIES ATHEROSCLEROTIC LESIONS IN PATIENTS WITH HEART ISCHEMIC DESEASES |
| |
- |
THE USE OF LOW-MOLECULAR HEPARIN IN PRAGNANTS |
| Vorobyeva N.A. |
- |
APPLICATION OF DISCRETE PLASMAPHERESIS IN TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME |
| |
- |
ANTITHROMBIN III IN COMPARISON WITH FRESH FROZEN PLASMA IN THE TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION ACCOMPANIED BY ANTITHROMBIN III DEFICIENCY |
| Vorobyova E.O. |
- |
HEMOSTASIS DISORDERS MARKERS IN INTRACRACRANIAL MENONGIOMAS (IM) PATIENTS |
| Vorobyova N. |
- |
INTERRELATION BETWEEN GENETIC POLYMORPHISM OF HEMOSTATIC SYSTEM AND CORONARY HEART DISEASE IN PATIENTS WITH OBESITY UNDERWENT CORONARY ARTERY BYPASS GRAFTING |
| Vorpahl F. |
- |
POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS |
| Vorster H. |
- |
ALCOHOL CONSUMPTION IS NOT ASSOCIATED WITH FIBRINOGEN IN A LARGE POPULATION OF AFRICAN BLACKS |
| Vos H.L. |
- |
POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION |
| |
- |
AQUAPORIN 2 GENE VARIATIONS, LEVELS OF VON WILLEBRAND FACTOR AND FACTOR VIII AND THE RISK OF VENOUS THROMBOSIS |
| |
- |
A CODING SNP AT THE GPI-ATTACHMENT SITE IN THE TFPI-BETA-SPECIFIC EXON IS ASSOCIATED WITH TFPI LEVELS |
| |
- |
SNPS NEAR THE ESTROGEN SULFOTRANSFERASE GENE SULT1E1 AND THE RISK OF VENOUS THROMBOSIS IN RELATION TO ORAL CONTRACEPTIVE USE |
| |
- |
THE EFFECT OF THE INTRONIC PROTHROMBIN 19911G ALLELE ON 3' END MRNA PROCESSING IN RELATION TO THE 20210GA POLYMORPHISM |
| |
- |
FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS |
| |
- |
HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN |
| |
- |
SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION |
| |
- |
FUNCTIONAL ANALYSIS OF SNPS SPECIFIC FOR HAPLOTYPE 1 (H1) OF THE GENE CODING FOR THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) |
| Voss R. |
- |
THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM |
| Vossen C.Y. |
- |
LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY |
| |
- |
THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER |
| Vossough P. |
- |
EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS |
| |
- |
EPIDEMIOLOGY OF BERNARD SOULIER DISEASE |
| |
- |
THROMBOSIS IN BETA THALASSEMIA MAJOR |
| Vranou M. |
- |
MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS |
| Vrbacky F.F.V. |
- |
FREQUENCY OF F II20210A IN WOMEN WITH VENOUS THROMBOEMBOLISM IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE |
| Vrelust I. |
- |
INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9 |
| Vretenbrant Öberg K. |
- |
PLATELET ACTIVATION VIA THROMBIN RECEPTOR PAR4 IS INVOLVED IN THE INITIATION OF THROMBIN GENERATION AND COAGULATION AND IN CLOT ELASTICITY DEVELOPMENT |
| |
- |
DIFFERENCES BETWEEN FIBRINOGEN BINDING AND RECEPTOR ACTIVATION MEASURED BY FLOW CYTOMETRY INDICATE THE EXISTENCE OF A TRANSITION STATE IN GPIIB/IIIA, RECOGNISED BY PAC-1 BUT NOT BINDING FIBRINOGEN |
| Vrignaud C. |
- |
THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS |
| Vu D. |
- |
MOLECULAR MECHANISMS ACCOUNTING FOR FIBRINOGEN DEFICIENCY: FROM LARGE DELETIONS TO INTRACELLULAR RETENTION OF MISFOLDED PROTEINS |
| |
- |
NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA |
| |
- |
RESCUE IN VITRO OF SECRETION-DEFECTIVE FIBRINOGEN MUTANTS CAUSING AFIBRINOGENEMIA |
| Vukelic Damijani N. |
- |
TREATMENT OF SURGICAL PATIENTS WITH FRESH FROZEN PLASMA AT THE CLINICAL HOSPITAL CENTER RIJEKA |
| Vukovich T. |
- |
ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE) |
| Vural O. |
- |
INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS |
| |
- |
LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS |
